Workflow
Sunshine Biopharma(SBFM)
icon
Search documents
Sunshine Biopharma(SBFM) - 2021 Q3 - Quarterly Report
2021-11-09 21:50
Table of Contents U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ______________ Commission File Number: 000-52898 SUNSHINE BIOPHARMA, INC. (Exact name of small business issuer as specified in its charter) Co ...
Sunshine Biopharma(SBFM) - 2021 Q2 - Quarterly Report
2021-08-09 16:01
Table of Contents U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ______________ Commission File Number: 000-52898 SUNSHINE BIOPHARMA, INC. (Exact name of small business issuer as specified in its charter) Colorad ...
Sunshine Biopharma(SBFM) - 2021 Q1 - Quarterly Report
2021-05-11 20:26
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Form 10-Q Quarterly Report Under the Securities Exchange Act of 1934 For Quarter Ended: March 31, 2021 Commission File Number: 000-52898 SUNSHINE BIOPHARMA, INC. (Exact name of small business issuer as specified in its charter) (State of other jurisdiction of incorporation) (IRS Employer ID No.) Colorado 20-5566275 6500 Trans-Canada Highway 4th Floor Pointe-Claire, Quebec, Canada H9R 0A5 (Address of principal executive offices) (514) 426-6161 (I ...
Sunshine Biopharma(SBFM) - 2020 Q4 - Annual Report
2021-03-30 19:24
U.S. SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark one) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2020 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF1934 for the transition period from ________________ to________________________. Commission File Number 000-52898 SUNSHINE BIOPHARMA, INC. (Exact name of registrant as specified in its charter) Colorado 20-5566275 (Sta ...